Kristin Abate insider trades

Open-market stock purchases and sales by Kristin Abate, Chief Accounting Officer at Karyopharm Therapeutics Inc, from SEC Form 4 filings since Feb 28, 2025.

Recent trades

DateStockTradeValue
Oct 16, 2026KPTI Karyopharm Therapeutics IncSold$1.6K
Oct 1, 2026KPTI Karyopharm Therapeutics IncSold$450
Sep 1, 2026KPTI Karyopharm Therapeutics IncSold$38
May 14, 2026KPTI Karyopharm Therapeutics IncSold$504
May 13, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—
Mar 2, 2026KPTI Karyopharm Therapeutics IncSold$5.3K
Jan 28, 2026KPTI Karyopharm Therapeutics IncSold$352
Jan 27, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—
Jan 21, 2026KPTI Karyopharm Therapeutics IncSold$1.6K

Companies traded

  • KPTI Karyopharm Therapeutics Inc: 12 sales, last Oct 16, 2026

Get free alerts when Kristin Abate files a new trade →